DENOSUMAB

DENOSUMAB was reported 203716 times

DENOSUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BONE GIANT CELL TUMOUR 309 0.7984
1 EXOSTOSIS OF JAW 298 0.6008
2 OSTEONECROSIS OF EXTERNAL AUDITORY CANAL 103 0.5150
3 ATYPICAL FRACTURE 231 0.3750
4 OSTEONECROSIS OF JAW 8703 0.3513
5 ATYPICAL FEMUR FRACTURE 893 0.3162
6 TOOTH RESORPTION 65 0.3066
7 DENTAL CARE 567 0.3060
8 DENTAL IMPLANTATION 412 0.2517
9 OESTROGEN DEFICIENCY 69 0.2509
10 ARTIFICIAL CROWN PROCEDURE 119 0.2419
11 PIK3CA-ACTIVATED MUTATION 76 0.2289
12 THORACIC VERTEBRAL FRACTURE 662 0.2235
13 DENTAL RESTORATION FAILURE 153 0.2122
14 EXPOSED BONE IN JAW 441 0.2033
15 BONE DENSITY ABNORMAL 721 0.1927
16 BLOOD PARATHYROID HORMONE INCREASED 555 0.1904
17 CARBOHYDRATE ANTIGEN 15-3 INCREASED 141 0.1853
18 HYPOCALCAEMIA 3390 0.1789
19 JAW OPERATION 157 0.1766
20 JAW DISORDER 953 0.1738
21 PATHOLOGICAL FRACTURE 849 0.1671
22 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1212 0.1579
23 ABSCESS JAW 162 0.1559
24 SPINAL FRACTURE 3000 0.1496
25 DENTAL FISTULA 62 0.1490
26 TOOTH DISORDER 3251 0.1461
27 DELUSION OF GRANDEUR 65 0.1448
28 LUMBAR VERTEBRAL FRACTURE 656 0.1430
29 LOOSE TOOTH 452 0.1402
30 OSTEOPOROTIC FRACTURE 264 0.1378
31 BLOOD CALCIUM ABNORMAL 226 0.1358
32 SPINAL DEFORMITY 217 0.1289
33 TOOTH EXTRACTION 1588 0.1275
34 ENDODONTIC PROCEDURE 309 0.1217
35 TRAUMATIC FRACTURE 88 0.1196
36 DENTAL OPERATION 275 0.1114
37 SEQUESTRECTOMY 74 0.1111
38 METASTASES TO BONE 1807 0.1100
39 COMPRESSION FRACTURE 575 0.1072
40 BLOOD ALKALINE PHOSPHATASE DECREASED 99 0.1043
41 BLOOD CALCIUM DECREASED 1160 0.1031
42 TOOTH FRACTURE 1102 0.0999
43 SPINAL COMPRESSION FRACTURE 821 0.0992
44 TEMPOROMANDIBULAR JOINT SYNDROME 264 0.0987
45 BLOOD PARATHYROID HORMONE ABNORMAL 62 0.0981
46 FRACTURED SACRUM 121 0.0973
47 GINGIVAL ABSCESS 72 0.0955
48 PAIN IN JAW 2704 0.0954
49 TERMINAL STATE 630 0.0941
50 PULPITIS DENTAL 86 0.0911
51 GROIN PAIN 786 0.0894
52 BONE GRAFT 82 0.0878
53 GINGIVAL RECESSION 168 0.0873
54 GINGIVAL DISORDER 333 0.0865
55 OCCUPATIONAL EXPOSURE TO PRODUCT 553 0.0859
56 FRACTURE 1621 0.0855
57 HYPERPARATHYROIDISM 172 0.0834
58 OSTEITIS 203 0.0804
59 PERIODONTITIS 174 0.0803
60 PROSTATE CANCER METASTATIC 264 0.0789
61 OSTEOSCLEROSIS 124 0.0787
62 METASTASES TO PLEURA 82 0.0782
63 TETANY 141 0.0773
64 BREAST CANCER METASTATIC 829 0.0771
65 ULNA FRACTURE 73 0.0737
66 METASTASES TO SPINE 247 0.0734
67 SENSITIVITY OF TEETH 127 0.0734
68 RADIUS FRACTURE 176 0.0732
69 METASTASES TO SKIN 74 0.0716
70 BONE PAIN 4082 0.0696
71 HYPOPHOSPHATAEMIA 513 0.0693
72 TOOTHACHE 1237 0.0683
73 JAW FRACTURE 147 0.0681
74 STRESS FRACTURE 367 0.0680
75 INVESTIGATION 210 0.0669
76 PERIODONTAL DISEASE 90 0.0641
77 HYPERCALCAEMIA 774 0.0626
78 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2109 0.0624
79 NONINFECTIVE GINGIVITIS 90 0.0621
80 METASTASES TO LYMPH NODES 402 0.0595
81 PELVIC FRACTURE 456 0.0585
82 ESSENTIAL HYPERTENSION 107 0.0584
83 BLOOD PHOSPHORUS DECREASED 211 0.0577
84 HUMERUS FRACTURE 271 0.0561
85 LYMPHOCYTE COUNT ABNORMAL 63 0.0560
86 GINGIVITIS 302 0.0559
87 DENTAL CARIES 618 0.0558
88 HORMONE-REFRACTORY PROSTATE CANCER 66 0.0556
89 BLOOD CALCIUM INCREASED 485 0.0552
90 MASTICATION DISORDER 166 0.0542
91 STREPTOCOCCAL SEPSIS 64 0.0540
92 TUMOUR MARKER INCREASED 257 0.0535
93 BODY HEIGHT DECREASED 571 0.0533
94 METASTASES TO LIVER 931 0.0529
95 FEMUR FRACTURE 1616 0.0521
96 GINGIVAL PAIN 415 0.0521
97 JOINT NOISE 101 0.0514
98 OSTEOLYSIS 105 0.0513
99 ORAL SURGERY 118 0.0504
100 TOOTH ABSCESS 511 0.0501
101 CANCER PAIN 127 0.0496
102 BLOOD PRESSURE SYSTOLIC ABNORMAL 122 0.0493
103 KYPHOSIS 87 0.0492
104 GINGIVAL SWELLING 217 0.0491
105 BONE LESION 177 0.0490
106 BONE DISORDER 889 0.0487
107 LIVING IN RESIDENTIAL INSTITUTION 91 0.0485
108 WRIST FRACTURE 579 0.0483
109 METASTASES TO LUNG 556 0.0481
110 CARCINOEMBRYONIC ANTIGEN INCREASED 91 0.0469
111 IMMOBILE 203 0.0464
112 HIP FRACTURE 1493 0.0464
113 MENOPAUSAL SYMPTOMS 108 0.0464
114 TOOTH INFECTION 611 0.0463
115 REBOUND EFFECT 520 0.0460
116 FEMORAL NECK FRACTURE 228 0.0444
117 PALLIATIVE CARE 68 0.0444
118 PROSTATIC SPECIFIC ANTIGEN INCREASED 603 0.0437
119 JOINT CREPITATION 85 0.0428
120 METASTASES TO MENINGES 97 0.0426
121 PATELLA FRACTURE 99 0.0424
122 OFF LABEL USE 36810 0.0420
123 PRODUCT STORAGE ERROR 3675 0.0419
124 BLOOD PRESSURE DIASTOLIC ABNORMAL 106 0.0416
125 FOOT FRACTURE 770 0.0406
126 VITAMIN D DECREASED 345 0.0403
127 SPONDYLOLISTHESIS 70 0.0403
128 OSTEOMYELITIS 726 0.0401
129 SPINAL PAIN 458 0.0390
130 TIBIA FRACTURE 183 0.0390
131 POLYMYALGIA RHEUMATICA 122 0.0384
132 ORAL INFECTION 150 0.0383
133 METASTASES TO PERITONEUM 96 0.0380
134 BONE DENSITY DECREASED 1190 0.0379
135 BREAST CANCER RECURRENT 118 0.0373
136 VITAMIN D DEFICIENCY 363 0.0372
137 INVASIVE DUCTAL BREAST CARCINOMA 101 0.0371
138 BONE LOSS 548 0.0364
139 SCOLIOSIS 224 0.0361
140 RIB FRACTURE 732 0.0356
141 HYPERPARATHYROIDISM SECONDARY 89 0.0355
142 LYMPHOEDEMA 243 0.0351
143 LICHEN PLANUS 80 0.0345
144 TOOTH LOSS 714 0.0344
145 SPINAL CORD COMPRESSION 133 0.0341
146 WALKING AID USER 225 0.0341
147 MUSCULOSKELETAL PAIN 1781 0.0340
148 FIBULA FRACTURE 97 0.0336
149 METASTASES TO CENTRAL NERVOUS SYSTEM 431 0.0334
150 CYSTITIS 1058 0.0332
151 LUMBAR SPINAL STENOSIS 97 0.0332
152 OSTEOPOROSIS 1358 0.0330
153 PERIARTHRITIS 74 0.0325
154 IMPAIRED HEALING 1057 0.0322
155 METASTASIS 227 0.0318
156 MULTIPLE FRACTURES 521 0.0317
157 BONE CANCER 137 0.0315
158 BREAST DISORDER 64 0.0313
159 ORAL DISORDER 228 0.0311
160 CALCINOSIS 69 0.0309
161 ADVERSE REACTION 408 0.0307
162 HOSPICE CARE 300 0.0303
163 BACK PAIN 7007 0.0301
164 SCIATICA 478 0.0300
165 NEOPLASM PROGRESSION 1029 0.0296
166 MEAN CELL VOLUME INCREASED 75 0.0292
167 EXOSTOSIS 266 0.0291
168 CLAVICLE FRACTURE 109 0.0284
169 CERVICAL VERTEBRAL FRACTURE 98 0.0284
170 TRISMUS 146 0.0282
171 ERYSIPELAS 140 0.0278
172 LOWER LIMB FRACTURE 533 0.0277
173 EAR PAIN 538 0.0276
174 SPINAL STENOSIS 113 0.0273
175 RADICULOPATHY 72 0.0273
176 MUSCULOSKELETAL DISCOMFORT 470 0.0273
177 CHEMOTHERAPY 103 0.0272
178 METASTATIC NEOPLASM 116 0.0269
179 HEPATIC CYST 91 0.0268
180 ORAL PAIN 593 0.0265
181 MUSCULOSKELETAL CHEST PAIN 405 0.0261
182 WEIGHT BEARING DIFFICULTY 70 0.0260
183 RHINALGIA 71 0.0258
184 VASCULAR DEVICE INFECTION 116 0.0255
185 SPINAL DISORDER 242 0.0255
186 THYROID MASS 97 0.0253
187 UPPER LIMB FRACTURE 502 0.0252
188 MOUTH SWELLING 145 0.0251
189 MYALGIA 4255 0.0250
190 ONYCHOCLASIS 172 0.0250
191 VARICOSE VEIN 127 0.0246
192 BEDRIDDEN 321 0.0244
193 SPINAL FUSION SURGERY 99 0.0244
194 MOBILITY DECREASED 1753 0.0244
195 HIP ARTHROPLASTY 373 0.0243
196 OSTEOARTHRITIS 1025 0.0242
197 PAIN IN EXTREMITY 7086 0.0240
198 DEATH 20701 0.0240
199 HYPERLIPIDAEMIA 286 0.0239
200 ESCHERICHIA URINARY TRACT INFECTION 100 0.0235
201 HEPATIC LESION 101 0.0233
202 OSTEONECROSIS 767 0.0233
203 HAND FRACTURE 165 0.0233
204 OSTEOPENIA 350 0.0230
205 SPINAL OPERATION 284 0.0230
206 REFUSAL OF TREATMENT BY PATIENT 149 0.0228
207 BLOOD MAGNESIUM DECREASED 194 0.0225
208 HIP SURGERY 120 0.0221
209 NERVE COMPRESSION 203 0.0220
210 MALIGNANT NEOPLASM PROGRESSION 2228 0.0217
211 ARTHRALGIA 9011 0.0216
212 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 368 0.0214
213 CATARACT OPERATION 127 0.0214
214 ANKLE FRACTURE 329 0.0212
215 BURSITIS 256 0.0211
216 HYPOMAGNESAEMIA 293 0.0210
217 PARONYCHIA 92 0.0209
218 INTERVERTEBRAL DISC DISORDER 89 0.0208
219 PEPTIC ULCER 69 0.0208
220 SPINAL OSTEOARTHRITIS 182 0.0207
221 ACTIVITIES OF DAILY LIVING IMPAIRED 408 0.0206
222 BLOOD CREATININE ABNORMAL 71 0.0205
223 RED CELL DISTRIBUTION WIDTH INCREASED 84 0.0202
224 PLANTAR FASCIITIS 67 0.0200
225 MUSCULOSKELETAL DISORDER 380 0.0199
226 DERMATITIS 406 0.0194
227 REHABILITATION THERAPY 75 0.0193
228 IMMUNE SYSTEM DISORDER 254 0.0193
229 EAR DISORDER 88 0.0192
230 INTERVERTEBRAL DISC DEGENERATION 177 0.0191
231 KNEE ARTHROPLASTY 401 0.0190
232 NECK PAIN 1044 0.0187
233 DIVERTICULITIS 512 0.0185
234 BACK DISORDER 300 0.0184
235 URINARY TRACT DISORDER 83 0.0184
236 ROTATOR CUFF SYNDROME 233 0.0181
237 FACIAL PAIN 161 0.0180
238 POLYNEUROPATHY 214 0.0179
239 BLOOD PRESSURE SYSTOLIC INCREASED 348 0.0178
240 CELLULITIS 898 0.0178
241 NAIL DISORDER 155 0.0177
242 BLOOD PRESSURE DIASTOLIC DECREASED 128 0.0173
243 SYNOVIAL CYST 80 0.0173
244 DECREASED IMMUNE RESPONSIVENESS 170 0.0173
245 TRIGGER FINGER 70 0.0171
246 PARAESTHESIA ORAL 247 0.0171
247 BLOOD CHOLESTEROL INCREASED 798 0.0171
248 ARTHROPATHY 951 0.0171
249 RASH PRURITIC 919 0.0169
250 HOSPITALISATION 2541 0.0165
251 PERIPHERAL VASCULAR DISORDER 85 0.0165
252 ROSACEA 76 0.0163
253 EYE OPERATION 75 0.0163
254 DIVERTICULUM INTESTINAL 71 0.0162
255 MOUTH ULCERATION 342 0.0162
256 FALL 5393 0.0162
257 INTERCEPTED MEDICATION ERROR 75 0.0162
258 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 105 0.0162
259 SPINAL COLUMN STENOSIS 76 0.0161
260 PULMONARY MASS 239 0.0160
261 POST PROCEDURAL INFECTION 130 0.0160
262 STOMATITIS 960 0.0158
263 HAEMOGLOBIN INCREASED 72 0.0158
264 URINARY TRACT INFECTION 2687 0.0157
265 MUCOSAL INFLAMMATION 410 0.0156
266 BLOOD CHOLESTEROL ABNORMAL 72 0.0156
267 BREAST MASS 104 0.0155
268 THERAPY PARTIAL RESPONDER 239 0.0153
269 MUSCLE DISORDER 124 0.0153
270 NECROSIS 84 0.0151
271 ADVERSE DRUG REACTION 1355 0.0151
272 APHTHOUS ULCER 117 0.0151
273 SKIN INFECTION 169 0.0151
274 JOINT RANGE OF MOTION DECREASED 202 0.0150
275 RHINITIS ALLERGIC 67 0.0150
276 ECZEMA 785 0.0150
277 ARTHRITIS 1174 0.0149
278 MUSCLE STRAIN 129 0.0149
279 SECOND PRIMARY MALIGNANCY 124 0.0149
280 PAPULE 105 0.0149
281 ADVERSE EVENT 1368 0.0148
282 WHITE BLOOD CELL COUNT DECREASED 1602 0.0148
283 HYDRONEPHROSIS 110 0.0147
284 SCAB 167 0.0146
285 DEMENTIA 409 0.0146
286 BLOOD ALBUMIN DECREASED 116 0.0146
287 WHEELCHAIR USER 65 0.0146
288 MUSCLE ATROPHY 185 0.0146
289 JOINT EFFUSION 100 0.0145
290 RASH VESICULAR 70 0.0145
291 NEOPLASM MALIGNANT 965 0.0144
292 INTERVERTEBRAL DISC PROTRUSION 316 0.0144
293 NEUTROPENIA 1965 0.0144
294 MUSCLE SPASMS 2652 0.0144
295 LEUKOPENIA 720 0.0144
296 HYPERAESTHESIA 117 0.0142
297 RED BLOOD CELL COUNT DECREASED 405 0.0142
298 HYPOAESTHESIA ORAL 213 0.0141
299 LIMB DISCOMFORT 437 0.0141
300 UNEVALUABLE EVENT 1066 0.0141
301 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 238 0.0140
302 JOINT DISLOCATION 148 0.0140
303 SKIN DISORDER 466 0.0140
304 GINGIVAL BLEEDING 190 0.0139
305 PLEURAL EFFUSION 846 0.0139
306 HAEMATOTOXICITY 132 0.0139
307 FINGER DEFORMITY 67 0.0138
308 ORAL DISCOMFORT 192 0.0138
309 MASS 193 0.0138
310 WRONG PRODUCT ADMINISTERED 93 0.0138
311 SKIN ABRASION 65 0.0137
312 CACHEXIA 70 0.0136
313 BLADDER DISORDER 135 0.0136
314 HOT FLUSH 1024 0.0136
315 MALNUTRITION 152 0.0136
316 ACCIDENTAL EXPOSURE TO PRODUCT 1400 0.0136
317 RASH GENERALISED 351 0.0135
318 MUSCLE TIGHTNESS 219 0.0135
319 BLOOD PRESSURE ABNORMAL 268 0.0135
320 BREAST PAIN 143 0.0134
321 MALABSORPTION 70 0.0134
322 NEUTROPHIL COUNT INCREASED 137 0.0134
323 TENDONITIS 207 0.0134
324 NON-SMALL CELL LUNG CANCER 64 0.0133
325 FOOT DEFORMITY 148 0.0133
326 SKIN MASS 89 0.0133
327 DYSURIA 489 0.0133
328 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 944 0.0133
329 THYROID DISORDER 204 0.0132
330 PRURITUS GENERALISED 286 0.0132
331 INFLUENZA LIKE ILLNESS 1087 0.0132
332 NEUTROPHIL COUNT DECREASED 538 0.0132
333 LYMPHOCYTE COUNT DECREASED 232 0.0131
334 BRUXISM 70 0.0130
335 NEUROPATHY PERIPHERAL 1233 0.0129
336 LIGAMENT SPRAIN 128 0.0129
337 LIMB OPERATION 62 0.0129
338 QUALITY OF LIFE DECREASED 173 0.0129
339 HYPERTRANSAMINASAEMIA 89 0.0128
340 CATARACT 762 0.0128
341 KIDNEY INFECTION 251 0.0128
342 GAIT DISTURBANCE 2447 0.0128
343 MICTURITION URGENCY 146 0.0128
344 ALOPECIA 2500 0.0127
345 FOOT OPERATION 63 0.0127
346 MACULAR DEGENERATION 152 0.0127
347 CANDIDA INFECTION 214 0.0127
348 TENDERNESS 132 0.0127
349 HIATUS HERNIA 164 0.0127
350 GLOMERULAR FILTRATION RATE DECREASED 155 0.0126
351 DYSSTASIA 368 0.0126
352 NEURALGIA 306 0.0126
353 UROSEPSIS 116 0.0126
354 SKIN TOXICITY 71 0.0126
355 DEAFNESS UNILATERAL 69 0.0125
356 KNEE OPERATION 123 0.0125
357 NEOPLASM 143 0.0124
358 LOCAL SWELLING 217 0.0124
359 EJECTION FRACTION DECREASED 193 0.0124
360 BODY TEMPERATURE DECREASED 122 0.0124
361 BLOOD TEST ABNORMAL 174 0.0124
362 BLOOD ALKALINE PHOSPHATASE INCREASED 307 0.0123
363 NEPHROLITHIASIS 567 0.0123
364 FIBROMYALGIA 300 0.0123
365 EXERCISE TOLERANCE DECREASED 71 0.0123
366 IMMUNOSUPPRESSION 108 0.0122
367 JOINT STIFFNESS 320 0.0122
368 LARGE INTESTINE POLYP 84 0.0121
369 INCONTINENCE 128 0.0121
370 INCORRECT ROUTE OF DRUG ADMINISTRATION 432 0.0121
371 HERPES ZOSTER 691 0.0120
372 LOW DENSITY LIPOPROTEIN INCREASED 93 0.0120
373 RENAL CYST 95 0.0119
374 POLYARTHRITIS 63 0.0119
375 IRON DEFICIENCY ANAEMIA 110 0.0119
376 SARS-COV-2 TEST POSITIVE 157 0.0119
377 FULL BLOOD COUNT DECREASED 238 0.0118
378 NODULE 154 0.0118
379 SQUAMOUS CELL CARCINOMA 111 0.0118
380 ARTHROPOD BITE 87 0.0117
381 GASTROOESOPHAGEAL REFLUX DISEASE 943 0.0117
382 HYPOTHYROIDISM 374 0.0117
383 DIVERTICULUM 83 0.0117
384 DECREASED ACTIVITY 126 0.0117
385 SURGERY 684 0.0117
386 SINUS DISORDER 231 0.0117
387 DISEASE PROGRESSION 1376 0.0116
388 NEUTROPENIC SEPSIS 83 0.0116
389 RESPIRATORY TRACT INFECTION 302 0.0116
390 POLLAKIURIA 481 0.0115
391 PAIN 7046 0.0115
392 SKIN REACTION 161 0.0114
393 DEVICE FAILURE 174 0.0114
394 LOCALISED INFECTION 276 0.0114
395 HYPERCHOLESTEROLAEMIA 110 0.0114
396 AUTOIMMUNE DISORDER 111 0.0114
397 PARAESTHESIA 1789 0.0114
398 CEREBRAL DISORDER 84 0.0113
399 FLANK PAIN 106 0.0113
400 DECUBITUS ULCER 92 0.0113
401 BLOOD URINE PRESENT 214 0.0113
402 PNEUMONITIS 306 0.0112
403 MENISCUS INJURY 69 0.0112
404 ANAEMIA 2139 0.0112
405 DEAFNESS 293 0.0112
406 ARTERIOSCLEROSIS CORONARY ARTERY 74 0.0112
407 HERPES VIRUS INFECTION 64 0.0111
408 EYE INFECTION 125 0.0111
409 RASH PAPULAR 248 0.0111
410 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 577 0.0110
411 TONGUE DISORDER 80 0.0110
412 GENERAL PHYSICAL HEALTH DETERIORATION 1278 0.0110
413 NOCTURIA 134 0.0110
414 EATING DISORDER 235 0.0110
415 ASTHENIA 4144 0.0110
416 LYMPHADENOPATHY 390 0.0110
417 VERTIGO 668 0.0109
418 POSTOPERATIVE WOUND INFECTION 74 0.0109
419 HYPOAESTHESIA 1638 0.0109
420 CARDIAC PACEMAKER INSERTION 65 0.0109
421 FULL BLOOD COUNT ABNORMAL 115 0.0109
422 C-REACTIVE PROTEIN INCREASED 395 0.0108
423 TASTE DISORDER 220 0.0108
424 EAR DISCOMFORT 111 0.0108
425 ILL-DEFINED DISORDER 656 0.0108
426 MUSCULAR WEAKNESS 1224 0.0108
427 GASTROINTESTINAL INFECTION 96 0.0107
428 RASH MACULAR 374 0.0107
429 DYSPNOEA EXERTIONAL 402 0.0107
430 BLOOD SODIUM DECREASED 201 0.0107
431 DECREASED APPETITE 2475 0.0106
432 HAEMATOCRIT DECREASED 211 0.0106
433 CONSTIPATION 2312 0.0106
434 FAECES SOFT 77 0.0106
435 FISTULA 119 0.0106
436 AFFECTIVE DISORDER 83 0.0105
437 ABASIA 260 0.0105
438 RASH ERYTHEMATOUS 503 0.0105
439 PELVIC PAIN 191 0.0105
440 GAIT INABILITY 351 0.0105
441 WHITE BLOOD CELL COUNT ABNORMAL 67 0.0105
442 BLOOD PRESSURE FLUCTUATION 252 0.0105
443 JOINT INJURY 224 0.0105
444 SEASONAL ALLERGY 148 0.0104
445 HAEMOGLOBIN ABNORMAL 67 0.0104
446 HYPOKALAEMIA 480 0.0104
447 BREAST CANCER 967 0.0104
448 LUNG INFECTION 161 0.0104
449 BLOOD COUNT ABNORMAL 157 0.0103
450 MUSCULOSKELETAL STIFFNESS 907 0.0103
451 GLAUCOMA 199 0.0103
452 HYPOKINESIA 150 0.0103
453 SKIN LESION 283 0.0103
454 PERIPHERAL SWELLING 1580 0.0102
455 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 239 0.0102
456 CARDIAC OPERATION 88 0.0102
457 SKIN ULCER 264 0.0102
458 DRY THROAT 103 0.0101
459 PLASMA CELL MYELOMA 395 0.0101
460 FATIGUE 7870 0.0101
461 BURNING SENSATION 707 0.0101
462 RASH 4388 0.0101
463 SKIN HAEMORRHAGE 149 0.0100
464 HYSTERECTOMY 87 0.0100
465 RASH PUSTULAR 73 0.0100
466 BLOOD DISORDER 80 0.0100
467 PERIPHERAL COLDNESS 137 0.0100
468 BRONCHIECTASIS 67 0.0099
469 SKIN LACERATION 108 0.0099
470 BRAIN NEOPLASM 91 0.0099
471 HAEMOGLOBIN DECREASED 1017 0.0099
472 ABSCESS 158 0.0099
473 ORAL CANDIDIASIS 130 0.0099
474 NIGHT SWEATS 317 0.0098
475 HAND DEFORMITY 129 0.0098
476 BRONCHITIS 728 0.0098
477 UPPER-AIRWAY COUGH SYNDROME 81 0.0098
478 LIMB INJURY 267 0.0098
479 ELECTROLYTE IMBALANCE 114 0.0098
480 ANAL INCONTINENCE 88 0.0098
481 CONTUSION 938 0.0097
482 URINARY INCONTINENCE 287 0.0097
483 WEIGHT DECREASED 2698 0.0097
484 GASTRITIS 254 0.0096
485 THERAPY NON-RESPONDER 433 0.0096
486 BLOOD IRON DECREASED 114 0.0096
487 IMMUNODEFICIENCY 143 0.0096
488 INCORRECT PRODUCT STORAGE 126 0.0096
489 TRANSIENT ISCHAEMIC ATTACK 323 0.0096
490 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 459 0.0095
491 RHINITIS 77 0.0095
492 HYPOACUSIS 411 0.0095
493 UPPER RESPIRATORY TRACT INFECTION 441 0.0095
494 EYE INFLAMMATION 91 0.0095
495 HYPOALBUMINAEMIA 74 0.0095
496 ASCITES 279 0.0095
497 ORAL HERPES 185 0.0095
498 COLON CANCER 141 0.0095
499 HYPERTENSION 2003 0.0094
500 VASCULITIS 110 0.0094
501 GAMMA-GLUTAMYLTRANSFERASE INCREASED 209 0.0094
502 RENAL IMPAIRMENT 792 0.0094
503 SLEEP DISORDER 665 0.0094
504 BLOOD POTASSIUM DECREASED 283 0.0094
505 ELECTROCARDIOGRAM QT PROLONGED 337 0.0094
506 ESCHERICHIA INFECTION 77 0.0094
507 DEVICE RELATED INFECTION 144 0.0093
508 GASTROINTESTINAL DISORDER 838 0.0093
509 SECRETION DISCHARGE 117 0.0093
510 HYPOPHAGIA 238 0.0093
511 FEELING COLD 259 0.0093
512 HEPATOTOXICITY 206 0.0092
513 RENAL DISORDER 431 0.0092
514 PRODUCT COMMUNICATION ISSUE 81 0.0092
515 NERVE INJURY 102 0.0092
516 FEEDING DISORDER 186 0.0092
517 SWELLING FACE 597 0.0092
518 GENERAL PHYSICAL CONDITION ABNORMAL 62 0.0091
519 INCREASED TENDENCY TO BRUISE 84 0.0091
520 ACCIDENT 109 0.0091
521 HYPERTHYROIDISM 132 0.0091
522 AORTIC ANEURYSM 69 0.0091
523 POST PROCEDURAL COMPLICATION 174 0.0091
524 EAR INFECTION 241 0.0090
525 LACERATION 85 0.0090
526 FACIAL PARALYSIS 77 0.0090
527 DYSPEPSIA 888 0.0090
528 INTERSTITIAL LUNG DISEASE 436 0.0090
529 WRONG DRUG ADMINISTERED 80 0.0090
530 ATRIAL FIBRILLATION 874 0.0090
531 BLISTER 504 0.0090
532 SKIN FISSURES 174 0.0089
533 LEUKAEMIA 84 0.0089
534 DIALYSIS 126 0.0089
535 LYMPHOMA 137 0.0089
536 DYSPHAGIA 838 0.0088
537 DRUG DOSE OMISSION 1459 0.0088
538 THROMBOCYTOPENIA 986 0.0088
539 LIP SWELLING 293 0.0088
540 PLATELET COUNT DECREASED 934 0.0088
541 MUSCLE TWITCHING 201 0.0087
542 ERYTHEMA MULTIFORME 81 0.0087
543 SKIN DISCOLOURATION 399 0.0087
544 RHEUMATOID ARTHRITIS 985 0.0087
545 PYELONEPHRITIS 75 0.0086
546 CONCUSSION 67 0.0086
547 PNEUMONIA 2794 0.0086
548 BACTERIAL INFECTION 161 0.0086
549 HEPATIC STEATOSIS 160 0.0086
550 LUNG NEOPLASM MALIGNANT 353 0.0086
551 ABNORMAL FAECES 70 0.0085
552 DYSPHONIA 499 0.0085
553 INFLUENZA 951 0.0085
554 MALAISE 3736 0.0085
555 POOR VENOUS ACCESS 88 0.0085
556 WOUND INFECTION 93 0.0085
557 BLOOD UREA INCREASED 142 0.0085
558 AGEUSIA 211 0.0085
559 DRY SKIN 1128 0.0084
560 DIARRHOEA 5441 0.0084
561 JOINT SWELLING 1017 0.0084
562 LABORATORY TEST ABNORMAL 248 0.0084
563 RENAL PAIN 89 0.0084
564 IRRITABLE BOWEL SYNDROME 180 0.0084
565 PULMONARY FIBROSIS 161 0.0084
566 DIZZINESS POSTURAL 81 0.0083
567 OEDEMA PERIPHERAL 1014 0.0083
568 BLOOD POTASSIUM INCREASED 135 0.0083
569 INFLAMMATION 429 0.0083
570 CLOSTRIDIUM DIFFICILE COLITIS 88 0.0083
571 CYST 103 0.0083
572 PRODUCTIVE COUGH 396 0.0083
573 SINUSITIS 850 0.0083
574 DISCOMFORT 504 0.0083
575 RHINORRHOEA 533 0.0082
576 THROAT TIGHTNESS 223 0.0082
577 BLOOD CREATININE INCREASED 538 0.0082
578 BRAIN OEDEMA 104 0.0082
579 RED BLOOD CELL SEDIMENTATION RATE INCREASED 91 0.0082
580 FLATULENCE 464 0.0082
581 GRIP STRENGTH DECREASED 72 0.0082
582 INFECTION 1180 0.0081
583 HEAD INJURY 258 0.0081
584 BLOOD THYROID STIMULATING HORMONE INCREASED 75 0.0081
585 COLITIS 308 0.0081
586 CHILLS 950 0.0081
587 BOWEL MOVEMENT IRREGULARITY 62 0.0081
588 HEAD DISCOMFORT 143 0.0081
589 CARPAL TUNNEL SYNDROME 113 0.0081
590 DYSGEUSIA 599 0.0081
591 WOUND 225 0.0080
592 PERICARDIAL EFFUSION 186 0.0080
593 GOUT 144 0.0080
594 MYOSITIS 72 0.0080
595 BALANCE DISORDER 691 0.0080
596 COUGH 2232 0.0080
597 COELIAC DISEASE 78 0.0079
598 OROPHARYNGEAL PAIN 736 0.0079
599 DRY MOUTH 645 0.0079
600 PRURITUS 3048 0.0079
601 OVARIAN CANCER 73 0.0079
602 LUNG DISORDER 387 0.0079
603 EPISTAXIS 587 0.0078
604 FURUNCLE 62 0.0078
605 RESPIRATORY DISORDER 234 0.0078
606 DEHYDRATION 1043 0.0078
607 GLOSSODYNIA 175 0.0078
608 BACK INJURY 85 0.0078
609 TINNITUS 359 0.0078
610 CHOLECYSTECTOMY 89 0.0078
611 SEPSIS 868 0.0078
612 TENDON RUPTURE 96 0.0078
613 PNEUMONIA BACTERIAL 71 0.0077
614 ULCER 123 0.0077
615 GASTROINTESTINAL PAIN 85 0.0077
616 FEELING ABNORMAL 1845 0.0077
617 TRANSAMINASES INCREASED 171 0.0077
618 MITRAL VALVE INCOMPETENCE 87 0.0077
619 ISCHAEMIC STROKE 137 0.0077
620 LOWER RESPIRATORY TRACT INFECTION 349 0.0077
621 PULMONARY EMBOLISM 727 0.0076
622 CHOLESTASIS 146 0.0076
623 BLOOD PRESSURE INCREASED 1158 0.0076
624 SKIN CANCER 163 0.0076
625 CLOSTRIDIUM DIFFICILE INFECTION 165 0.0076
626 SMALL INTESTINAL OBSTRUCTION 93 0.0075
627 BASAL CELL CARCINOMA 117 0.0075
628 LIVER FUNCTION TEST INCREASED 161 0.0075
629 FEELING HOT 457 0.0074
630 NASOPHARYNGITIS 1371 0.0074
631 EMPHYSEMA 75 0.0074
632 ACUTE RESPIRATORY FAILURE 143 0.0074
633 URINARY RETENTION 248 0.0074
634 VIRAL INFECTION 245 0.0074
635 EYE DISORDER 242 0.0074
636 ATELECTASIS 71 0.0073
637 PHARYNGITIS 91 0.0073
638 DERMATITIS ALLERGIC 92 0.0073
639 PANCYTOPENIA 408 0.0073
640 RETINAL DETACHMENT 67 0.0073
641 GASTRIC DISORDER 250 0.0073
642 MYELOSUPPRESSION 262 0.0073
643 ARTERIOSCLEROSIS 68 0.0072
644 INSOMNIA 1923 0.0072
645 DRY EYE 360 0.0072
646 BRAIN FOG 113 0.0072
647 RESTLESS LEGS SYNDROME 131 0.0072
648 GASTROENTERITIS VIRAL 130 0.0072
649 OROPHARYNGEAL DISCOMFORT 65 0.0072
650 DERMATITIS CONTACT 82 0.0072
651 ABDOMINAL DISCOMFORT 1203 0.0072
652 PAIN OF SKIN 193 0.0072
653 IMPAIRED DRIVING ABILITY 81 0.0071
654 LIVER DISORDER 312 0.0070
655 NAUSEA 5568 0.0070
656 HERNIA 136 0.0070
657 HEPATIC CIRRHOSIS 132 0.0070
658 SCRATCH 74 0.0070
659 ERYTHEMA 1436 0.0070
660 CHOLELITHIASIS 229 0.0070
661 BODY TEMPERATURE INCREASED 142 0.0070
662 HYPONATRAEMIA 392 0.0070
663 SKIN EXFOLIATION 586 0.0069
664 MALIGNANT MELANOMA 93 0.0069
665 PNEUMOTHORAX 110 0.0069
666 PYREXIA 2391 0.0069
667 SWOLLEN TONGUE 215 0.0069
668 PULMONARY THROMBOSIS 75 0.0069
669 GASTROENTERITIS 100 0.0068
670 THROMBOSIS 551 0.0068
671 CEREBROVASCULAR ACCIDENT 1159 0.0068
672 SCAR 117 0.0068
673 MEMORY IMPAIRMENT 937 0.0068
674 HAEMORRHOIDS 133 0.0068
675 PETECHIAE 71 0.0068
676 ARRHYTHMIA 322 0.0068
677 RESPIRATORY TRACT CONGESTION 108 0.0068
678 ASPARTATE AMINOTRANSFERASE INCREASED 359 0.0068
679 URTICARIA 1131 0.0067
680 DRUG EFFECT INCOMPLETE 245 0.0067
681 APHONIA 94 0.0067
682 INJURY ASSOCIATED WITH DEVICE 137 0.0067
683 ABDOMINAL PAIN LOWER 170 0.0067
684 DYSPNOEA 3802 0.0067
685 CYTOPENIA 82 0.0067
686 CARDIAC DISORDER 626 0.0067
687 OESOPHAGITIS 73 0.0067
688 ABDOMINAL DISTENSION 696 0.0067
689 HEPATIC CYTOLYSIS 85 0.0067
690 CARDIAC FAILURE 535 0.0067
691 THERAPY CESSATION 341 0.0066
692 BLOOD LACTATE DEHYDROGENASE INCREASED 105 0.0066
693 OEDEMA 358 0.0066
694 SUPRAVENTRICULAR TACHYCARDIA 63 0.0066
695 ABDOMINAL PAIN UPPER 1339 0.0065
696 THERAPY INTERRUPTED 464 0.0065
697 HYPERSOMNIA 186 0.0065
698 COVID-19 1138 0.0065
699 MOTOR DYSFUNCTION 66 0.0065
700 SWELLING 605 0.0065
701 GENERALISED OEDEMA 80 0.0065
702 DIABETES MELLITUS 491 0.0064
703 COVID-19 PNEUMONIA 76 0.0064
704 DRUG ERUPTION 114 0.0064
705 ALANINE AMINOTRANSFERASE INCREASED 393 0.0064
706 HYPERTENSIVE CRISIS 71 0.0064
707 MADAROSIS 74 0.0064
708 SYNCOPE 637 0.0064
709 PULMONARY OEDEMA 285 0.0064
710 LEUKOCYTOSIS 115 0.0063
711 ADRENAL INSUFFICIENCY 77 0.0063
712 PROCEDURAL PAIN 175 0.0063
713 SALIVARY HYPERSECRETION 63 0.0063
714 RETCHING 134 0.0063
715 LETHARGY 361 0.0063
716 ORTHOSTATIC HYPOTENSION 109 0.0063
717 CONJUNCTIVITIS 116 0.0062
718 SLEEP APNOEA SYNDROME 119 0.0062
719 SENSORY DISTURBANCE 100 0.0062
720 OXYGEN SATURATION DECREASED 350 0.0062
721 LACRIMATION INCREASED 188 0.0062
722 SINUS CONGESTION 84 0.0062
723 CARDIAC FAILURE CONGESTIVE 499 0.0062
724 DIZZINESS 3098 0.0062
725 UVEITIS 84 0.0062
726 HAEMATURIA 212 0.0062
727 HYPERGLYCAEMIA 225 0.0062
728 GASTRIC ULCER 117 0.0061
729 INITIAL INSOMNIA 63 0.0061
730 POOR QUALITY SLEEP 132 0.0061
731 HAIR TEXTURE ABNORMAL 82 0.0061
732 BLOOD BILIRUBIN INCREASED 165 0.0061
733 CARDIOMEGALY 75 0.0061
734 PRODUCT ADMINISTRATION ERROR 123 0.0061
735 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 432 0.0061
736 VENTRICULAR EXTRASYSTOLES 63 0.0061
737 PLATELET COUNT INCREASED 79 0.0061
738 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1086 0.0060
739 ABDOMINAL PAIN 1399 0.0060
740 TRANSFUSION 63 0.0060
741 LYMPHOPENIA 85 0.0060
742 SCHIZOPHRENIA 73 0.0060
743 PNEUMONIA ASPIRATION 150 0.0060
744 CHEST PAIN 1112 0.0060
745 HEADACHE 3764 0.0060
746 RASH MACULO-PAPULAR 133 0.0060
747 HEPATIC FAILURE 180 0.0060
748 DEEP VEIN THROMBOSIS 387 0.0059
749 ROAD TRAFFIC ACCIDENT 249 0.0059
750 FUNGAL INFECTION 198 0.0059
751 THIRST 106 0.0059
752 FAECES DISCOLOURED 128 0.0059
753 BLOOD TRIGLYCERIDES INCREASED 104 0.0059
754 HYPERSENSITIVITY 1083 0.0058
755 DISABILITY 115 0.0058
756 PARALYSIS 83 0.0058
757 ANGINA PECTORIS 166 0.0058
758 VOMITING 2719 0.0058
759 NERVOUSNESS 302 0.0058
760 ERUCTATION 111 0.0057
761 MELAENA 126 0.0057
762 COMPLICATION ASSOCIATED WITH DEVICE 83 0.0057
763 GALLBLADDER DISORDER 102 0.0057
764 SNEEZING 128 0.0057
765 IMPAIRED QUALITY OF LIFE 82 0.0057
766 JAUNDICE 153 0.0057
767 HEPATOCELLULAR INJURY 80 0.0056
768 HYPERKALAEMIA 197 0.0056
769 PULMONARY CONGESTION 74 0.0056
770 EYE SWELLING 208 0.0056
771 INTESTINAL OBSTRUCTION 209 0.0055
772 PALPITATIONS 648 0.0055
773 HEART RATE IRREGULAR 125 0.0055
774 CEREBRAL INFARCTION 135 0.0055
775 HEART RATE INCREASED 542 0.0055
776 RECTAL HAEMORRHAGE 235 0.0055
777 NEEDLE ISSUE 159 0.0055
778 OBESITY 87 0.0055
779 HEPATIC ENZYME INCREASED 371 0.0054
780 HEART RATE DECREASED 191 0.0054
781 THROAT IRRITATION 243 0.0054
782 CHRONIC KIDNEY DISEASE 410 0.0054
783 DIPLOPIA 140 0.0054
784 RENAL FAILURE 714 0.0054
785 TYPE 2 DIABETES MELLITUS 181 0.0054
786 CONFUSIONAL STATE 867 0.0054
787 LIVER FUNCTION TEST ABNORMAL 156 0.0054
788 NASAL CONGESTION 315 0.0054
789 CHOKING 104 0.0053
790 FLUID RETENTION 271 0.0053
791 BLINDNESS 217 0.0053
792 FEBRILE NEUTROPENIA 353 0.0053
793 EYE HAEMORRHAGE 71 0.0053
794 WHITE BLOOD CELL COUNT INCREASED 203 0.0053
795 DRUG INTOLERANCE 511 0.0053
796 CHROMATURIA 119 0.0053
797 MUSCLE RIGIDITY 63 0.0053
798 INTENTIONAL DOSE OMISSION 150 0.0053
799 DEPRESSED MOOD 278 0.0053
800 DEPRESSION 1192 0.0052
801 EPILEPSY 160 0.0052
802 PHOTOSENSITIVITY REACTION 86 0.0052
803 ACUTE HEPATIC FAILURE 71 0.0052
804 EYE PAIN 293 0.0052
805 CORONARY ARTERY DISEASE 157 0.0052
806 WEIGHT INCREASED 1161 0.0052
807 PRESYNCOPE 126 0.0052
808 INTRAOCULAR PRESSURE INCREASED 66 0.0052
809 HEPATIC FUNCTION ABNORMAL 192 0.0051
810 AMNESIA 331 0.0051
811 MIDDLE INSOMNIA 95 0.0051
812 PROSTATE CANCER 408 0.0051
813 DELIRIUM 176 0.0051
814 DRUG EFFECT LESS THAN EXPECTED 75 0.0051
815 SEPTIC SHOCK 220 0.0051
816 ILLNESS 520 0.0050
817 ACUTE KIDNEY INJURY 768 0.0050
818 SYSTEMIC LUPUS ERYTHEMATOSUS 177 0.0050
819 CHEST DISCOMFORT 510 0.0050
820 RESPIRATORY FAILURE 361 0.0049
821 PHARYNGEAL OEDEMA 76 0.0049
822 HYPOTENSION 985 0.0049
823 PULMONARY HYPERTENSION 102 0.0049
824 BLOOD PRESSURE DECREASED 325 0.0049
825 ASTHMA 549 0.0049
826 HALLUCINATION, AUDITORY 77 0.0048
827 HAEMOPTYSIS 135 0.0048
828 SPEECH DISORDER 253 0.0048
829 BLOOD GLUCOSE ABNORMAL 89 0.0048
830 ACUTE MYOCARDIAL INFARCTION 142 0.0048
831 STAPHYLOCOCCAL INFECTION 158 0.0048
832 HYPERHIDROSIS 614 0.0048
833 COLD SWEAT 84 0.0048
834 HAEMATOMA 123 0.0047
835 FACE OEDEMA 80 0.0047
836 BREAST CANCER FEMALE 126 0.0047
837 MOVEMENT DISORDER 151 0.0047
838 VISUAL IMPAIRMENT 582 0.0047
839 DISORIENTATION 186 0.0047
840 CARDIOMYOPATHY 69 0.0047
841 INJECTION SITE RASH 143 0.0047
842 MYELODYSPLASTIC SYNDROME 67 0.0046
843 COGNITIVE DISORDER 216 0.0046
844 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 931 0.0046
845 THERAPEUTIC PRODUCT EFFECT DECREASED 205 0.0046
846 HEPATITIS 117 0.0046
847 DRUG-INDUCED LIVER INJURY 143 0.0046
848 TREMOR 756 0.0046
849 PALLOR 122 0.0045
850 ANXIETY 1270 0.0045
851 DIABETES MELLITUS INADEQUATE CONTROL 79 0.0045
852 TREATMENT NONCOMPLIANCE 244 0.0045
853 IMPAIRED WORK ABILITY 95 0.0044
854 LOSS OF CONSCIOUSNESS 569 0.0044
855 INTENTIONAL PRODUCT USE ISSUE 389 0.0044
856 RESTLESSNESS 162 0.0044
857 MYOCARDIAL INFARCTION 771 0.0044
858 PERICARDITIS 74 0.0044
859 INJECTION SITE PAIN 1337 0.0044
860 VISION BLURRED 597 0.0043
861 FREQUENT BOWEL MOVEMENTS 117 0.0043
862 INFUSION RELATED REACTION 284 0.0043
863 MIGRAINE 408 0.0043
864 NERVOUS SYSTEM DISORDER 133 0.0043
865 SYNOVITIS 75 0.0042
866 PANCREATITIS 219 0.0041
867 PRODUCT DOSE OMISSION IN ERROR 116 0.0041
868 MULTIPLE ORGAN DYSFUNCTION SYNDROME 116 0.0041
869 CEREBRAL HAEMORRHAGE 146 0.0041
870 WHEEZING 241 0.0041
871 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 119 0.0041
872 HYPOXIA 143 0.0041
873 THERAPEUTIC RESPONSE UNEXPECTED 182 0.0041
874 INCREASED APPETITE 77 0.0040
875 SEIZURE 465 0.0040
876 ANGIOEDEMA 178 0.0040
877 EYE PRURITUS 135 0.0040
878 PROTEINURIA 76 0.0040
879 HAEMATOCHEZIA 220 0.0040
880 ANAPHYLACTIC SHOCK 102 0.0040
881 PRODUCT DOSE OMISSION ISSUE 1163 0.0040
882 HALLUCINATION, VISUAL 81 0.0038
883 CONTRAINDICATED PRODUCT ADMINISTERED 116 0.0038
884 TACHYCARDIA 340 0.0038
885 PANCREATITIS ACUTE 86 0.0038
886 APHASIA 115 0.0038
887 DRUG INTERACTION 595 0.0037
888 BONE MARROW FAILURE 76 0.0037
889 OCULAR HYPERAEMIA 176 0.0037
890 DRUG DOSE OMISSION BY DEVICE 289 0.0037
891 INTENTIONAL PRODUCT MISUSE 323 0.0037
892 CONDITION AGGRAVATED 1108 0.0036
893 SKIN IRRITATION 166 0.0036
894 EYE IRRITATION 207 0.0036
895 FEELING JITTERY 68 0.0036
896 GLYCOSYLATED HAEMOGLOBIN INCREASED 90 0.0036
897 SOMNOLENCE 715 0.0035
898 CARDIOVASCULAR DISORDER 90 0.0035
899 HAEMORRHAGE 367 0.0035
900 PRODUCT DOSE OMISSION 228 0.0035
901 HEPATIC CANCER 83 0.0035
902 HYPOGLYCAEMIA 166 0.0034
903 MENTAL STATUS CHANGES 95 0.0034
904 DISTURBANCE IN ATTENTION 182 0.0034
905 PANCREATIC CARCINOMA 97 0.0034
906 RHABDOMYOLYSIS 140 0.0034
907 AGRANULOCYTOSIS 62 0.0033
908 INJECTION SITE SWELLING 249 0.0032
909 BLOOD CREATINE PHOSPHOKINASE INCREASED 93 0.0032
910 FEAR 86 0.0032
911 HAEMATEMESIS 81 0.0032
912 GASTROINTESTINAL HAEMORRHAGE 267 0.0032
913 HALLUCINATION 240 0.0032
914 PSYCHOTIC DISORDER 94 0.0032
915 EXTRAPYRAMIDAL DISORDER 79 0.0032
916 MENTAL IMPAIRMENT 77 0.0032
917 MENTAL DISORDER 138 0.0032
918 RESPIRATORY DISTRESS 87 0.0031
919 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 81 0.0031
920 PERITONITIS 65 0.0031
921 DEVICE DIFFICULT TO USE 207 0.0031
922 FLUSHING 316 0.0031
923 VAGINAL HAEMORRHAGE 134 0.0031
924 ACNE 234 0.0031
925 THERAPEUTIC RESPONSE DECREASED 187 0.0031
926 UNDERDOSE 225 0.0031
927 DYSARTHRIA 116 0.0031
928 INJECTION SITE MASS 113 0.0031
929 VISUAL ACUITY REDUCED 101 0.0030
930 DRUG RESISTANCE 78 0.0030
931 INJECTION SITE REACTION 206 0.0030
932 INJURY 210 0.0030
933 PSORIATIC ARTHROPATHY 121 0.0030
934 ALTERED STATE OF CONSCIOUSNESS 64 0.0030
935 DYSKINESIA 115 0.0028
936 ANAPHYLACTIC REACTION 156 0.0028
937 EMOTIONAL DISORDER 86 0.0028
938 MEDICATION ERROR 155 0.0028
939 ENCEPHALOPATHY 68 0.0028
940 INJECTION SITE PRURITUS 183 0.0027
941 INJECTION SITE ERYTHEMA 338 0.0027
942 PRODUCT PRESCRIBING ERROR 64 0.0027
943 INJECTION SITE BRUISING 213 0.0027
944 CRYING 95 0.0026
945 DEVICE ISSUE 233 0.0026
946 COLITIS ULCERATIVE 116 0.0026
947 BLOOD GLUCOSE INCREASED 487 0.0026
948 MOOD SWINGS 82 0.0026
949 DRUG INEFFECTIVE 3303 0.0025
950 PANIC ATTACK 91 0.0025
951 CARDIAC ARREST 206 0.0025
952 MULTIPLE SCLEROSIS 119 0.0025
953 SKIN BURNING SENSATION 176 0.0025
954 INTERNATIONAL NORMALISED RATIO INCREASED 70 0.0025
955 DEVICE USE ERROR 85 0.0024
956 SEDATION 64 0.0024
957 PRODUCT USE ISSUE 455 0.0024
958 THERAPEUTIC RESPONSE SHORTENED 80 0.0024
959 TREATMENT FAILURE 196 0.0024
960 DEVICE BREAKAGE 96 0.0024
961 PSORIASIS 298 0.0023
962 RENAL FAILURE ACUTE 96 0.0023
963 PRODUCT USE IN UNAPPROVED INDICATION 552 0.0022
964 DISEASE RECURRENCE 105 0.0022
965 METABOLIC ACIDOSIS 69 0.0022
966 BRADYCARDIA 111 0.0021
967 EXPIRED PRODUCT ADMINISTERED 69 0.0021
968 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 107 0.0019
969 BLOOD GLUCOSE DECREASED 91 0.0019
970 AGITATION 138 0.0019
971 DRUG EFFECT DECREASED 99 0.0018
972 CARDIO-RESPIRATORY ARREST 76 0.0018
973 IRRITABILITY 105 0.0017
974 INCORRECT DOSE ADMINISTERED 395 0.0017
975 EXTRA DOSE ADMINISTERED 68 0.0017
976 COMA 79 0.0017
977 DEPRESSED LEVEL OF CONSCIOUSNESS 64 0.0016
978 INJECTION SITE HAEMORRHAGE 120 0.0015
979 RENAL CANCER 69 0.0014
980 TOXICITY TO VARIOUS AGENTS 234 0.0014
981 BLADDER CANCER 81 0.0014
982 CONVULSION 77 0.0013
983 SUICIDAL IDEATION 119 0.0013
984 DEVICE MALFUNCTION 76 0.0011
985 EMOTIONAL DISTRESS 130 0.0011
986 OVERDOSE 228 0.0011
987 MULTIPLE SCLEROSIS RELAPSE 62 0.0009
988 PRODUCT QUALITY ISSUE 93 0.0007
989 NO ADVERSE EVENT 101 0.0006
990 DRUG DEPENDENCE 74 0.0005